PUBMED FOR HANDHELDS

Journal Abstract Search


274 related items for PubMed ID: 10831641

  • 1. Short-term recombinant human growth hormone therapy does not modify growth hormone, thyrotropin and prolactin responses to thyrotropin-releasing hormone in adult dialysis patients.
    Iglesias P, Selgas R, Méndez J, Fernández-Reyes MJ, Bajo MA, Aguilera A, Díez JJ.
    Nephrol Dial Transplant; 2000 Jun; 15(6):856-61. PubMed ID: 10831641
    [Abstract] [Full Text] [Related]

  • 2. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ, Iglesias P, Sastre J, Gómez-Pan A.
    Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
    [Abstract] [Full Text] [Related]

  • 3. Influence of long term erythropoietin therapy on the hypothalamic-pituitary-thyroid axis in patients undergoing capd.
    Tokgöz B, Utaş C, Doğukan A, Oymak O, Keleştimur F.
    Ren Fail; 2002 May; 24(3):315-23. PubMed ID: 12166698
    [Abstract] [Full Text] [Related]

  • 4. Influence of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in uremic patients.
    Díez JJ, Iglesias PL, Sastre J, Gómez-Pan A, Selgas R, Martínez-Ara J, Miguel JL, Méndez J.
    Kidney Int; 1994 Nov; 46(5):1387-91. PubMed ID: 7853798
    [Abstract] [Full Text] [Related]

  • 5. Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Bajo MA, Aguilera A, Méndez J, Codoceo R, Selgas R.
    Nephrol Dial Transplant; 2002 Feb; 17(2):260-4. PubMed ID: 11812876
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.
    Nephron; 1996 Feb; 74(3):548-54. PubMed ID: 8938679
    [Abstract] [Full Text] [Related]

  • 7. [The effect of recombinant human growth hormone on thyroid function in patients with growth hormone deficiency].
    Tang D, Wang J, Wu C.
    Zhonghua Nei Ke Za Zhi; 1997 Nov; 36(11):754-8. PubMed ID: 10451949
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
    Jensen PB, Hansen TB, Frystyk J, Ladefoged SD, Pedersen FB, Christiansen JS.
    Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
    [Abstract] [Full Text] [Related]

  • 9. Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.
    De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Liberale I, Mignani V, Pennisi M, Della Corte F.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):741-7. PubMed ID: 10468946
    [Abstract] [Full Text] [Related]

  • 10. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 11. Thyrotrophin, prolactin and growth hormone responses to TRH in barbiturate coma and in depression.
    Naeije R, Golstein J, Zegers De Beyl D, Linkowski P, Mendlewicz J, Copinschi G, Badawi M, Leclercq R, L'Hermite M, Vanhaelst L.
    Clin Endocrinol (Oxf); 1978 Jul; 9(1):49-58. PubMed ID: 98247
    [Abstract] [Full Text] [Related]

  • 12. Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues.
    Van den Berghe G, de Zegher F, Baxter RC, Veldhuis JD, Wouters P, Schetz M, Verwaest C, Van der Vorst E, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1998 Feb; 83(2):309-19. PubMed ID: 9467533
    [Abstract] [Full Text] [Related]

  • 13. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J, Límanová Z, Srámková J.
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [Abstract] [Full Text] [Related]

  • 14. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE, Scanniffio D, Bonomo SM, Cella SG, Sartorio A, Müller EE.
    Neuroendocrinology; 2004 Oct; 79(5):237-46. PubMed ID: 15218318
    [Abstract] [Full Text] [Related]

  • 15. Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis.
    Della Corte F, Mancini A, Valle D, Gallizzi F, Carducci P, Mignani V, De Marinis L.
    Crit Care Med; 1998 Aug; 26(8):1419-26. PubMed ID: 9710103
    [Abstract] [Full Text] [Related]

  • 16. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
    Giusti M, Lomeo A, Torre R, Sghedoni D, Mazzocchi G, Durante R, Giordano G.
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
    [Abstract] [Full Text] [Related]

  • 17. The relationship of changes in serum estradiol and progesterone during the menstrual cycle to the thyrotropin and prolactin responses to thyrotropin-releasing hormone.
    Sawin CT, Hershman JM, Boyd AE, Longcope C, Bacharach P.
    J Clin Endocrinol Metab; 1978 Dec; 47(6):1296-302. PubMed ID: 122427
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone responses to oral glucose and intravenous thyrotropin-releasing hormone in acromegalic patients treated by slow-release lanreotide.
    Díez JJ, Iglesias P, Gómez-Pan A.
    J Endocrinol Invest; 2001 May; 24(5):303-9. PubMed ID: 11407648
    [Abstract] [Full Text] [Related]

  • 19. Lack of effect of hexarelin on TRH-induced TSH response in normal adult man.
    Arosio M, Casati G, Biella O, Porretti S, Imbimbo BP, Faglia G.
    J Endocrinol Invest; 1998 Apr; 21(4):239-44. PubMed ID: 9624598
    [Abstract] [Full Text] [Related]

  • 20. Triiodothyronine administration reduces serum growth hormone levels and growth hormone responses to thyrotropin-releasing hormone in patients with anorexia nervosa.
    Valcavi R, Zini M, Portioli I.
    Psychoneuroendocrinology; 1990 Apr; 15(4):287-95. PubMed ID: 2128417
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.